АКРОМЕГАЛИЯ ВА ИККИЛАМЧИ “БЎШ” ТУРК ЎРИНДИҒИ СИНДРОМИ БЎЛГАН БЕМОРЛАРНИНГ ҲАЁТ СИФАТИНИ ХАЛҚАРО АCРО-ҚОЛ СЎРОВНОМАСИ ЁРДАМИДА БАҲОЛАШ
##article.subject##:
акромегалия, качество жизни, Acro-Qol##article.abstract##
Тадқиқотнинг мақсади Аcро-Қол сўровномаси ёрдамида акромегали ва иккиламчи "бўш" турк егар синдроми билан оғриган беморларнинг ҳаёт сифатини баҳолаш еди.
Тадқиқот материаллари ва усуллари. Академик Е. H. Тўрақулов номидаги Ўзбекистон Республикаси Соғлиқни сақлаш вазирлиги Республика ихтисослаштирилган Ендокринология илмий-амалий тиббиёт марказининг нейроендокринология бўлимида 2022 йилдан 2023 йилгача акромегалия ва вспт билан касалланган 70 нафар бемор тиббий кўрикдан ўтказилди. 70 беморнинг 43 нафари еркаклар ва 27 нафари аёллар еди. Ўртача ёш 48,4, 14,8 ёшни ташкил етди.
Натижалар. Даволанишдан 3 ва 6 ой ўтгач, аcро-Қол сўровномаси ёрдамида баҳоланган акромегали билан оғриган беморларнинг ҳаёт параметрлари барча гуруҳларда (п<0.005), енг муҳими, Тег гуруҳидаги беморларда ошди.
Хулоса. 1. Бизнинг маълумотларимизга кўра, депрессия акромегали билан оғриган беморларнинг 1/3 қисмида (28% гача) содир бўлган, аёл жинси ва ташвиш билан боғлиқ. Депрессия ҳам, ташвиш ҳам муҳим ва мустақил ҳисса қўшади
Библиографические ссылки
Webb SM, Prieto L, Badia X, Albareda M, Catalá M, Gaztambide S, Lucas T, Páramo C, Picó A, Lucas A, Halperin I, Obiols G, Astorga R. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. //Clin Endocrinol (Oxf). 2002;57(2): 251–8. doi: 10.1046/j.1365-2265.2002.01597.x.
Webb SM, Badia X, Surinach NL; Spanish AcroQol Study Group. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. //Eur J Endocrinol. 2006;155(2): 269–77. doi: 10.1530/eje.1.02214.
Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C, Biermasz NR. Predictors of quality of life in acromegaly: no consensus on biochemical parameters. //Front Endocrinol (Lausanne). 2017;8:40. doi: 10.3389/ fendo.2017.00040.
van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol (Oxf). 2008 Jul;69(1):123-8. doi: 10.1111/j.1365-2265.2007.03169.x.
Cangiano B, Giusti E, Premoli C, Soranna D, Vitale G, Grottoli S, Cambria V, Mantovani G, Mungari R, Maffei P, Dassie F, Giampietro A, Chiloiro S, Tanda ML, Ippolito S, Cannavò S, Ragonese M, Zambon A, Persani L, Fatti LM, Scacchi M; “PRO-ACRO” study group on Motor Disability in Acromegaly, of the Italian Society of Endocrinology (SIE). Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine. 2022 Sep;77(3):510-518. doi: 10.1007/s12020-022-03106-8
C. Sievers, C. Dimopoulou, H. Pfister et al. Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin. Endocrinol.(Oxf) 71, 691–701 (2009)
D.M. Szczesniak, A. Jawiarczyk-Przybylowska, L. Matusiak et al. Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity? Endokrynol. Pol. 68, 524–532 (2017)
E. Karathanasi, M. Poulasouchidou, D. Selalmatzidou et al. Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? Endocrine 47, 564–571 (2014)
C. Dimopoulou, S.M. Leistner, M. Ising et al. Body Image Perception in Acromegaly Is Not Associated with Objective Acromegalic Changes but Depends on Depressive Symptoms. Neuroendocrinology 105, 115–122 (2017)
J. Tiemensma, A.M. Pereira, J.A. Romijn et al. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: Novel application of the drawing test. Eur. J. Endocrinol. 172, 583–593 (2015)
P. Pantanetti, N. Sonino, G. Arnaldi, M. Boscaro, Self Image and Quality of Life in Acromegaly. Pituitary 5, 17–19 (2002)
C. Sievers, M. Ising, H. Pfister et al. Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls. Eur. J. Endocrinol. 160, 367–373 (2009)
V.J. Geraedts, C. Dimopoulou, M. Auer et al. Health outcomes in acromegaly: Depression and anxiety are promising targets for improving reduced quality of life. Front Endocrinol. 5, 1–7 (2014)
S.M. Webb, L. Prieto, X. Badia et al. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin. Endocrinol. 57, 251–258 (2002)
P.J. Trainer, W.M. Drake, L. Katznelson et al. Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant. N. Engl.
J. Med. 342, 1171–1177 (2000)
